News
February 14, 2019
Safety of Long term use of Hydroxychloroquine Therapy Further Verified for People with Lupus
Hydroxychloroquine (Plaquenil®) was approved by the Food and Drug Administration for symptoms of lupus. The greatest concern people with lupus have when taking hydroxychloroquine is related to vision and an increase in risk for retinal damage. A new investigation analyzed the retinal changes over a five-year period in people with lupus and did not find clinically relevant retinal changes in the group. The study concludes that hydroxychloroquine therapy is safe for long-term use at doses <5 mg/kg/day. Learn about how lupus affects the eyes and hydroxychloroquine.
See More:
The latest from Inside Lupus Research
News
New Treatment Guidelines for Systemic Lupus Erythematosus for Children and Adults
News
New Treatment Guidelines for Lupus Nephritis Shift Focus to Continuous Therapy
News
Data Suggests CAR-T Therapy Shows Promise for Lupus Treatment
News
Study Finds Potential Link Between Higher BMI and Disordered Eating Attitudes in Women with Systemic Lupus Erythematosus